Skip to content

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00196287
Enrollment
750
Registered
2005-09-20
Start date
1995-01-31
Completion date
Unknown
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Assessment, risk, autonomic nervous system, Gender

Brief summary

The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.

Interventions

None listed

Sponsors

Deutsches Herzzentrum Muenchen
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

acute myocardial infarction; female gender

Exclusion criteria

\-

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026